'Effects of adding L-arginine orally to standard therapy in pa | Robert W Malone, MD

"Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis"
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00405-3/fulltext
...
"Strikingly, patients treated with L-arginine exhibited a significantly reduced in-hospital stay vs placebo, with a median (interquartile range 25th,75th percentile) of 46 days (45,46) in the placebo group vs 25 days (21,26) in the L-arginine group (p < 0.0001)"

Follow and Share
@RWMaloneMD